FDA Approves Secuado (asenapine) Transdermal System for the Treatment of Adults with Schizophrenia

Article Link: FDA Approves Secuado (asenapine) Transdermal System for the Treatment of Adults with Schizophrenia

Miami, FL And Jersey City, NJ, October 15, 2019 — Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S. Food and Drug Administration (FDA) has approved Secuado (asenapine)…

Source: FDA New Drug Approvals